Catalyst Calendar

Wed, Aug 12, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder

Trial Results • Phase 3Topline results release Wed, Aug 12, 2026, 7:00 AM EDTdefiniumtx.com

Thu, Aug 6, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Trial Results • Phase 3Results event Mon, Jun 30, 2025, 4:30 PM EDTdefiniumtx.com

Mon, Aug 3, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jul 30, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

definiumtx.com

Mon, Jul 20, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jul 16, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology

definiumtx.com

Tue, Jul 14, 2026

1 updates

DFTX

7:00 AM

New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)

definiumtx.com

Mon, Jul 6, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, Jun 25, 2026

1 updates

DFTX

4:15 PM

Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

definiumtx.com

Tue, Jun 23, 2026

1 updates

DFTX

9:57 PM

Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering

definiumtx.com

Mon, Jun 22, 2026

2 updates

DFTX

4:01 PM

Definium Therapeutics, Inc. Announces Proposed Public Offering

definiumtx.com

DFTX

7:00 AM

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

Trial Results • Phase 3Topline results Mon, Jun 22, 2026, 7:00 AM EDTdefiniumtx.com

Sun, Jun 21, 2026

1 updates

DFTX

5:00 PM

Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026

Results Call • Phase 3Results call Mon, Jun 22, 2026, 8:00 AM EDTdefiniumtx.com

Mon, Jun 15, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Mon, Jun 1, 2026

1 updates

DFTX

4:01 PM

Definium Therapeutics Announces New Employee Inducement Grants

definiumtx.com

Thu, May 21, 2026

1 updates

DFTX

7:00 AM

Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

definiumtx.com